Actient Pharmaceuticals has acquired Timm Medical Technologies, a provider in products and services for the diagnosis and treatment of urological disorders, primarily in the area of erectile dysfunction.
Subscribe to our email newsletter
With this acquisition, Actient Pharma is able to offer pharmaceutical, and medical device and diagnostic solutions to the urology community.
Actient Pharma CEO Ed Fiorentino said they look forward to combine the companies and expanding their efforts in providing urology products and services that improve patient outcomes.
Timm Medical president David Talen said they believe that Actient will help enhance their position as a valued resource for urologists and patients.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.